LabCompass

Rabheh Abdul‐Aziz

Medicine · The Ohio State University

Mid career · publishing since 2014

Publications

39

Citations

641

Est. group size

Recurring co-author estimate

Active years

12

Publishing since 2014

Research summary
AI-generated

Rabheh Abdul-Aziz works in pediatric rheumatology, focusing on autoimmune and inflammatory conditions in children such as juvenile idiopathic arthritis, systemic lupus erythematosus, vasculitis, and multisystem inflammatory syndrome in children (MIS-C) related to COVID-19. Much of the published work consists of case reports and case series describing unusual or difficult-to-diagnose presentations, alongside some clinical outcome studies and reviews on immune system mechanisms like the complement pathway. This body of work would be relevant to students interested in clinical pediatric rheumatology and immunology research.

Pediatric rheumatologyJuvenile idiopathic arthritisAutoimmune and inflammatory diseases in childrenComplement system and immune disordersCOVID-19-related inflammatory syndromes (MIS-C)

Publication output has fluctuated over the past decade, peaking around 2020-2021 (likely tied to COVID-19/MIS-C case reporting) and settling to a steady average of about 3 publications per year in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.0/year recently
2017: 3 publications17182019: 2 publications192020: 7 publications202021: 8 publications8212022: 3 publications222023: 5 publications232024: 3 publications242025: 4 publications2526
Recent publications
Publishes in
  • Cureus×11
  • The Journal of Immunology×3
  • Progress in Pediatric Cardiology×2
  • Pediatric Rheumatology×2
  • Case Reports in Rheumatology×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile